|
 |
Park S, Choi YL, Sung CO, An J, Seo J, Ahn MJ, Ahn JS, Park K, Shin YK, Erkin OC, Song K, Kim J, Shim YM, Han J. High MET copy number and MET overexpression: poor outcome in non-small cell lung cancer patients. Histol Histopathol. 2012 Feb;27(2):197-207., 2012 |
|
|
|
|
|
Mi Jeong Kwon, Sarah Park, Jun Young Choi, Ensel Oh, Yu Jin Kim, Yeon-Hee Park, Eun Yoon Cho, Mi Jung Kwon, Seok Jin Nam, Young-Hyuck Im, Shin YK, Yoon-La Choi. Clinical Significance of CD151 Overexpression in Subtypes of Invasive Breast Cancer. Br J Cancer. 2012 106, 923-930, 2012 |
|
|
|
|
|
Ensel Oh, Yoon-La Choi, Taesung Park, Seungyeoun Lee, Seok Jin Nam, Young Kee Shin. A prognostic model for lymph node-negative breast cancer patients based on the integration of proliferation and immunity. Breast Cancer Res Treat.2012 132:499-509, 2012 |
|
|
|
|
|
Kwon MJ*, Kim SH*, Jeong HM, HS Jung, Kim SS, Lee JE, Gye MC, OC Erkin, Koh SS, Choi YL, Park CK, Shin YK. Claudin-4 overexpression is associated with epigenetic derepression in gastric carcinoma. Laboratory Investigation, 91, 1652-1667, 2011 |
|
|
|
|
|
Jung HS, Erkin OC, Kwon MJ, Kim SK, Shin H-J, Jung JI, Oh Y-K, Her SW, Ju W, Choi Y-L, Kim JK, Shin YK. Human Papillomavirus E6/E7 siRNA Potentiates the Therapeutic Effect of Cisplatin in Cervical Cancer Cell Lines In vitro and In vivo. Int J Cancer. In press, 2011 |
|
|
|
|
|
Jung HS, Shin YK. The Potential RNAi-based Combination Therapeutics. Arch Pharm Res. 2011;34(1):1-2. Commentary, 2011 |
|
|
|
|
|
Choi JW, Kim DG, Lee A-E, Kim HR, Lee JY, Kwon NH, Shin YK, Hwang S-K, Chang S-H, Cho M-H, Choi Y-L, Kim J, Oh SH, Kim B, Kim S-Y, Jeon H-S, Park JY, Kang HP, Park BJ, Han JM, Kim S. Cancer-associated Splicing Variant of Tumor Suppressor AIMP2/p38: Pathological Implication in Tumorigenesis. PLOS Genet. 2011 Mar 7;3:e1001351, 2011 |
|
|
|
|
|
Jung HS, Choi Y-L, Choi J-S, Roh JH, Pyon J-K, Woo K-J, Lee EH, Jang K-T, Han J, Park C-S, Park YS, Shin YK. Detection of Merkel Cell Polyomavirus in Merkel Cell Carcinomas and Small Cell Carcinomas by PCR and Immunohistochemistry. Histol Histopathol. In press., 2011 |
|
|
|
|
|
Kwon MJ, Shin YK. Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer. Int J Mol Sci. 2011;12:983-1008. Invited review, 2011 |
|
|
|
|
|
Woo K-J, Choi Y-L, Jung HS, Jung K-S, Shin YK, Jang K-T, Han J, P J-K. Merkel Cell Carcinoma: Our Experience with Seven Patients in Korea and a Literature Review. J PLAST RECONSTR AES. 2010 Dec;63(12):2064-70., 2010 |
|
|
|
|
|
Yoon-La Choi, Ensel Oh, Sarah Park, Yeonju Kim, Yeon-Hee Park, Kyug Song, Eun Yoon Cho, Yun-Chul Hong, Jong Sun Choi, Jung Eun Lee, Jung Han Kim, Seok Jin Nam, Young-Hyuk Lim, Jung-Hyun Yang, Young Kee Shin. Triple-Negative, Basal-like, and Quintuple-Negative Breast Cancers : Better Prediction Model for Survival. BMC Cancer, 2010 Sep 23;10:507-521. Highly accessed, 2010 |
|
|
|
|
|
Jochen K.M. Lennerz, Seok-Hyung Kim, Edward L. Oates, Won Jae Huh, Jason M. Doherty, Xiaolin Tian, Andrew J. Bredemeyer, James R. Goldenring, Gregory Y. Lauwers, Young-Kee Shin, Jason C. Mills. The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia and carcinoma. Am J Pathol, 2010 Sep;177(3):1514-33, 2010 |
|
|
|
|
|
Choi Y-L, Bocanegra M, Kwon MJ, Shin YK, Nam SJ, Yang J-H, Kao J, Godwin AK, Pollack JR. LYN Is a Mediator of Epithelial-Mesenchymal Transition and a Target of Dasatinib in Breast Cancer. Cancer Res 2010 Mar 15;70(6):2296-306, 2010 |
|
|
|
|
|
Kwon MJ, Kim SS, Choi YL, Jung HS, Balch C, Kim SH, Song YS, Marquez VE, Nephew KP, Shin YK. Derepression of CLDN3 and CLDN4 during Ovarian Tumorigenesis Is Associated with Loss of Repressive Histone Modifications. Carcinogenesis. 2010 Jan;31(6): 974-983. featured on MDLinx, 2010 |
|
|
|
|
|
Lee MH, Choi BY, Kundu JK, Shin YK, Na HK and Surh YJ. Resveratrol Suppresses Growth of Human Ovarian Cancer Cells in Culture and in a Murine Xenograft Model: Eukaryotic Elongation Factor 1A2 as a Potential Target.(2009.09) Cancer Res 2009;69(18):7449-7458, 2009 |
|
|
|
|
|
Kwon MJ, Oh E, Lee S, Roh MR, Kim SE, Lee Y, Choi YL, In YH, Park T, Koh SS, Shin YK.(2009.07) Identification of Novel Reference Genes Using Multiplatform Expression Data and Their Validation for Quantitative Gene Expression Analysis. PLoS One 2009 Jul 7;4(7):e6162, 2009 |
|
|
|
|
|
Kim KH, Kim JM, Choi YL, Shin YK, Lee HC, Seong IO, Kim BK, Chae SW, Chung YS and Kim SH.(2009.05) Expression of Sonic hedgehog signaling molecules in normal, hyperplastic and carcinomatous endometrium. Pathology International 2009; 59:279-287, 2009 |
|
|
|
|
|
Yin HQ, Je YT, Kim YC, Shin YK, Sung SH, Lee KY, Jeong GS, Kim YC, and Lee BH. (2009.04) Magnolia officinalis Reverse Alcoholic Fatty Liver by Inhibiting the Maturation of Sterol Regulatory Element-Binding Protein-1c J Pharmacol Sci 109,486-495(2009), 2009 |
|
|
|
|
|
Kim HJ, Kim JH, Shin YK, Lee SI, Ahn KM. A novel mutation in the linker domain of the signal transducer and activator of transcription 3 gene, p.Lys531Glu, in hyper-lgE syndrome. Allergy Clinical Immunology 2009 Apr;123(4):956-8, 2009 |
|
|
|
|
|
Hu-Quan Yin, Youn-Chul Kim, Young-Suk Chung, Young-Chul Kim, Young-Kee Shin, Byung-Hoon Lee. (2009.04) Honokiol reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element binding protein-1c and the expression of its downstream lipogenesis genes Toxicology and Applied Pharmacology 236(2009)124-130, 2009 |
|
|
|
|
|
Na TY, Shin YK, Hong I, Kang S, Seong JK, Park CK, Choi YL, Lee MO. Liver X receptor mediates Hepatitis B virus X protein-induced lipogenesis in Hepatitis B virus-associated hepatocellular carcinoma. Hepatology. 2009 Apr;49(4):1122-31., 2009 |
|
|
|
|
|
Kim KH, Choi JS, Kim JM, Choi YL, Shin YK, Lee HC, Seong IO, Kim BK, Chae SW, Kim SH. (2009.03) Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium. Histol & Histopathol. Mar; 24(3):309-316., 2009 |
|
|
|
|
|
Choi YJ, Choi YL, Cho EY, Shin YK, Sung KW, Hwang YK, Lee SJ, Kong G, Lee JE, Kim JS, Kim JH, Yang JH, Nam SJ. (2009.01) Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients. Breast Cancer Res Treat. Jan; 113(1):83-93, 2009 |
|
|
|
|
|
Kundu JK, Hwang DM, Lee JC, Chang EJ, Shin YK, Fujii H, Sun B and Surh YJ. (2009.01) Inhibitory effects of oligonol on phorbol ester-induced tumor promotion and COX-2 expression in mouse skin: NF-kB and C/EBP as potential targets. Cancer Lett.. Jan; 273(1):86-97, 2009 |
|
|
|
|
|
Kim SH, Lee S-H, Choi Y-L, Wang L-H, Park CK, Shin YK. (2008) Extensive alteration inthe expression profiles of TGFB pathway signaling components and TP53 is observed along the gastric dysplasia-carcinoma sequence. Histol & Histopathol. Dec; 23(12): 1439-1452., 2008 |
|
|
|
|
|
Yang YD, Cho H, Koo JY, Tak MH, Cho Y, Shim W-S, Park SP, Lee J, Lee B, Kim B-M, Raouf R, Shin YK, Uhtaek Oh. (2008) TMEM16A confers receptor-activated calcium-dependent chloride conductance. Nature. Oct; 455(7217):1210-1215., 2008 |
|
|
|
|
|
Wang LH, Yang JY, Cui W, Shin YK, Wu CF. (2008) Involvement of promyelocytic leukemia protein in the ethanol-induced apoptosis in mouse embryo fibroblasts. Yakugaku Zasshi. Jul;128(7):1067-1071., 2008 |
|
|
|
|
|
Yoo Y-G, Na T-Y, Seo HW, Seong JK, Park CK, Shin YK, Lee M-O. (2008) Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene. May:27(24):3405-3413, 2008 |
|
|
|
|
|
Choi HJ, Shin YK, Lee HJ, Kee JY, Shin DW, Lee EY, Lee YJ, Lee EB, Song YW.(2008) The Clinical Significance of serum N-terminal Pro-Brain Natriuretic Peptide in Systemic Sclerosis patients. Clin Reumatol. Apr ;27(4):437-442., 2008 |
|
|
|
|
|
Lee M-H, Kim Y-A, Na T-Y, Kim S-H, Shin YK, Lee B-H, Shin H-S, Lee M-O. (2008) Identification of formaldehyde-responsive genes by suppression subtractive hybridization. Toxicology. Jan;243(1-2):224-235., 2008 |
|
|
|
|
|
Woo SU, Bae JW, Jang J-H, Kim JH, Nam SJ, Shin YK. (2007) Overexpression of interleukin-10 in sentinel lymph node with breast cancer. Annals of Surgical Oncology. Nov;14(11):3268-3273., 2007 |
|
|
|
|
|
Choi Y-L, Kim J, Kwon MJ, Choi J-S, Bae D-S, Kim T-J, Koh SS, In Y-H, Park YW, Kim SH, Ahn G, Shin YK.
Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation. Histol & Histopathol. Nov;22(11):1185-1195, 2007 |
|
|
|
|
|
Lee JH, Kim SH, Wang LH, Choi YL, Kim YC, Kim JH, Park TS, Hong YC, Shin YK. Clinical Significance of CD99 Down-Regulation in Gastric Adenocarcinoma. Clinical Cancer Res. May 1;13(9):2584-91., 2007 |
|
|
|
|
|
Xuan YH, Choi YL, Shin YK, Ahn GH, Kim KH, Kim WJ, Lee HC, Kim SH. The expression of TGF-b signaling molecules in normal placenta and gestational trophoblastic disease. Histol & Histopathol. Mar;22(3):227-234., 2007 |
|
|
|
|
|
Choi Y-L, Lee S-H, Kwon G-Y, Park C-K, Han J-J, Choi J-S, Choi H-Y, Kim S-H, Kim S-H, Shin YK. Overexpression of CD24: Association with Invasiveness in Urothelial Carcinoma of Bladder. Archives of Pathology & Laboratory Medicine Feb; 131:275-281., 2007 |
|
|
|
|
|
Wang L-H, Kim S-H, Lee JH, Choi Y-L, Kim YC, Park TS, Hong Y-C, Wu C-F, Shin YK. Inactivation of SMAD4 Tumor Suppressor Gene During Gastric Carcinoma Progression. Clinical Cancer Res Jan 1;13(1):102-110. Cover article, 2007 |
|
|
|
|
|
Kundu JK, Shin YK, Surh Y-J. Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-<kappa>B and AP-1 as prime targets. Biochem Pharm. Nov 30;72(11):1506-1515., 2006 |
|
|
|
|
|
Xuan YH, Jung HS, Choi Y-L, Shin YK, Kim HJ, Kim KH, Kim WJ, Lee YJ, Kim S-H. Enhanced expression of hedgehog signaling molecules in squamous cell carcinoma of uterine cervix and its precursor lesions. Modern Pathology. Aug;19(8):1139-1147, 2006 |
|
|
|
|
|
Park T, Yi S-G, Choi H, Shin YK, Lee SY. Combining Multiple Microarrays in the Presence of Controlling Variables. Bioinformatics. Jul 15;22(14):1682-1689., 2006 |
|
|
|
|
|
Kundu JK, Shin YK, Surh Y-J. Reveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-kB in mouse skin by blocking IkB kinase-b activity. Carcinogenesis Jul;27(7):1465-1474., 2006 |
|
|
|
|
|
Wang L-H*, Choi Y-L*, Hua X-Y, Shin YK, Song Y-J, Youn S-J, Yun H-Y, Park S-M, Kim W-J, Kim H-J, Choi J-S, Kim S-H. Increased expression of sonic hedgehog and altered methylation of its promoter region in gastric cancer and its related lesions. Modern Pathology. May;19(5):675-683., 2006 |
|
|
|
|
|
Kim SS, Kang C, Shin CY, Hwang SW, Yang YD, Shim W, Park M-Y, Kim E, Kim M, Kim B, Cho H, Shin YK, Oh U. TRPV1 recapitulates native capsaicin receptor in sensory neurons in association with Fas-associated factor 1. J Neurosci. Mar 1;26(9):2403-2412., 2006 |
|
|
|
|
|
Choi Y-L, Kang SY, Shin YK, Kim SH, Ahn G. Aberrant hypermethylation of RASSF1A promoter in ovarian borderline tumors and carcinomas. Virchow Arch Mar 448(3):331-336., 2006 |
|
|
|
|
|
Park SH, Shin YK, Suh YH, Park HJ, Ban YL, Choi H-S, Jung KC. Rapid divergency of rodent CD99 Orthologs: Implications for the evolution of the pseudoautosomal region. GENE Jul 4;353(2):177-88., 2005 |
|
|
|
|
|
Park SG, Kim HJ, Min YH, Choi EC, Shin YK, Park BJ, Lee SW, Kim S. Human lysyl-tRNA synthetase is secreted to trigger pro-inflammatory response. Proc Natl Acad Sci U S A. May 3;102(18):6356-61., 2005 |
|
|
|
|
|
Choi YL, Kim SH, Shin YK, Hong YC, Lee SJ, Kang SY, Ahn G. Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors. Gynecol Oncol May;97(2):379-386., 2005 |
|
|
|
|
|
Choi YL, Kim CJ, Matsuo T, Gaetano C, Falconi R, Suh Y-L, Kim SH, Shin YK, Park SH, Chi JG, Thiele CJ. hUlip, a Human homologue of unc-33-like phosphoprotein of Caenorhabditis elegans Immunohistochemical localization in human developing brain and patterns of expression in nervous system tumors. J Neu-Oncol. May;73(1):19-27., 2005 |
|
|
|
|
|
Kim SO, Kundu JK, Shin YK, Park J-H, Cho M-H, Kim T-Y, Surh Y-J. [6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-kB in phorbol ester-stimulated mouse skin. Oncogene. 07 April 24(15): 2558-2567., 2005 |
|
|
|
|
|
Park SG, Shin HS, Shin YK, Lee Y, Choi E-C, Park B-J, Kim S. A novel cytokine p43 stimulates dermal fibroblast proliferation and wound repair. Am J Pathol. Feb 166(2): 387-398, 2005 |
|
|
|
|
|
Park B-J, Kang JW, Lee SW, Choi S-J, Shin YK, Ahn YH, Choi YH, Choi D, Lee KS, Kim S. The Haploinsufficient Tumor Suppressor p18 Upregulates p53 via Interactions with ATM/ATR. Cell. Jan 120(2): 209-221., 2005 |
|
|
|
|
|
Xuan YH, Choi YL, Shin YK, Kook MC, Chae SW, Park SM, Chae HB, Kim SH. Immunohistochemical study of expression of cell cycle regulated proteins p53, cyclin D1, RB, p27, and MSH2 in gallbladder carcinoma and its precursor lesions. Histology and Histopathology. Jan; 20(1):59-66, 2005 |
|
|
|
|
|
Kim SH, Kook MC, Shin YK, Park SH, Song HG Evaluation of antigen retrieval buffer systems for the improved immunostaining of formalin-fixed and paraffin embedded tissues. J Mol Histol 35:409-416., 2004 |
|
|
|
|
|
Kim H-Y, Kim YM, Shin YK,Park SH, Lee W. Solution structure of the cytoplasmic domain of human CD99 type I. Mol Cell 18:24-29., 2004 |
|
|
|
|
|
Choi YL, Xuan YH, Shin YK, Chae SW, Kook MC, Sung RH, Youn SJ, Choi JW, Kim SH. An immunohistochemical study of the expression of adhesion molecules in gallbladder lesions. J Histochem Cytochem 52:591-601., 2004 |
|
|
|
|
|
Kim H-Y, Shin J, Shin YK, Park SH, Lee W. NMR and circular dichroism studies on human CD99 Transmembrane Domain. Journal of the Korean Magnetic Resonance Society 7:37-45., 2003 |
|
|
|
|
|
Suh YH, Shin YK, Kook MC, Oh KI, Park WS, Kim SH, Lee I-S, Park HJ, Huh T-L, Park SH. Cloning, genomic organization, alternative transcripts and expression analysis of CD99L2, a novel paralog of human CD99, and identification of evolutionary conserved motifs. Gene 307:63-76., 2003 |
|
|
|
|
|
Shin YK*, Choi YL*, Choi EY, Kim MK, Kook MC, Chung J, Choi YK, Kim HS, Song HG, Park SH. Targeted Cytotoxic effect of anti-JL1 immunotoxin against a human leukemic cell line and its clinical implications. Cancer Immunol Immunother 52:506-512 (* equally contributed), 2003 |
|
|
|
|
|
Kim SH, Shin YK, Lee KM, Lee JS, Yun JH, Lee SM. An Improved Protocol of Biotinylated Tyramine-based Immunohistochemistry Minimizing Nonspecific Background Staining. J Histochem Cytochem 51:129-132., 2003 |
|
|
|
|
|
Chung JH, Park SJ, Kim DJ, Chung H-K, Park S-C, Kim IJ, Choi IH, Chung HG, Yi KS, Ryu SH, Suh PG, Chung DH, Bae YM, Shin YK, Park SH. Identification of antigenic peptide recognized by the anti-JL1 leukemia-specific monoclonal antibody from combinatorial peptide phage display libraries. J Cancer Res Clin Oncol 128:641-649., 2002 |
|
|
|
|
|
Kim SH, Jung KC, Shin YK, Lee KM, Park YS, Choi YL, Oh KI, Kim MK, Chung DH, Song HG, Park SH. The enhanced reactivity of endogenous biotin-like molecules by antigen retrieval procedures and signal amplification with tyramine. Histochem J 34:97-103., 2002 |
|
|
|
|
|
Suh YH, Kim MK, Shin YK, Kim SH, Oh KI, Gil M, Kim MK, Choi YL, Jung KC, Lee KM, Lee IS, Park SH. Mutations of the immunoglobulin heavy chain variable region gene in CD99-deficient BJAB cell line. Mol Cells 13:237-244., 2002 |
|
|
|
|
|
Lee IS, Shin YK, ChungDH, Park SH. LMP1-induced downregulation of CD99 molecules in Hodgkin and Reed-Sternberg cells. Leukemia lymphoma 42:587-594., 2001 |
|
|
|
|
|
Shin YK, Kim SH, EY Choi, Park SH. Immature thymocyte antigen, JL1, as a possible immunodiagnostic and immunotherapeutic target for leukemia. Immune network 1:1-9., 2001 |
|
|
|
|
|
Shin YK, Choi EY, Kim SH, Chung J, Chung DH, Park WS, Jung KC, Kim HS, Park S, Kim HJ, Park MH, Min CK, Kim CC, Park SH. Expression of leukemia-associated antigen, JL1, in bone marrow and thymus. Am J Pathol 158:1473-1486., 2001 |
|
|
|
|
|
Sohn HW, Shin YK, Lee IS, Bae YM, Suh YH, Kim MK, Kim TJ, Park WS, Kim K, Kim IS, Ko YH, Park SH. CD99 regulates the transport of MHC class I from the Golgi complex to the cell surface. J Immunol 166:787-794., 2001 |
|
|
|
|
|
Kim SH*, Shin YK*, Lee IS, Bae YM, Sohn HW, Ree Howe J., Rowe M, Park SH. Viral latent membrane protein 1(LMP-1)-induced CD99 down-regulation in B cells leads to the generation of cells with Hodgkin's and Reed-Sternberg phenotype. Blood 95:294-300. (* equally contributed), 2000 |
|
|
|
|
|
Shin YK, Lee GK, Kook MC, Jun KC, Kim JR, Song HG, Park SH, Chi JG. Reduced expression of CD99 and functional disturbance in anencephalic cortical thymocytes. Virchows Arch 434:443-449., 1999 |
|
|
|
|
|
Park CK, Shin YK, Kim TJ, Park SH, Ahn GH. High CD99 Expression in Memory T and B Cells in Reactive Lymph Nodes. J Korean Med Sci 14:600-606., 1999 |
|
|
|
|
|
Kim SH*, Choi EY*, Shin YK, Kim TJ, Chung DH, Chang SI, Kim NK, Park SH. Generation of cells with Hodgkin's and Reed-Sternberg phenotype through downregulation of CD99 (Mic2). Blood 92:4287-4295, 1998 |
|
|
|
|
|
|
|
|
Ji-man Kang, Jungmin Suh, Jihyun Kim, Hee-Jin Kim, Yae-jean Kim, Hun Seok Lee, Young Kee Shin, Kangmo Ahn, and Sang-Il Lee. A case of Hyper-IgE syndrome with a mutation of the STAT3 gene. Korean Journal of Pediatrics Vol. 53, No. 4, 2010 |
|
|
|
|
|
|
|
|
Hun-Soon Jung, Mi-Hyun Cho, Young-Kee Shin. The long-term combined cisplatin and synthetic E6 siRNA treatment synergistically augments their therapeutic effects on cervical cancer cells (11.6-7) 2nd International Conference on Toxicogenomics, 2006 |
|
|
|
|
|
Mi Jeong Kwon, Ensel Oh, Seungmook Lee, Mi Ra Roh, Yong-Ho In, Taesung Park, Sang Seok Koh, Young Kee Shin. Identification of endogenous reference genes using gene expression data produced by EST, SAGE and oligonucleotide microarray. (11.6-7) 2nd International Conference on Toxicogenomics, 2006 |
|
|
|
|
|
Ensel Oh, Mira Roh, Seoung Mook Lee, Mi Jeong Kwon, Yong-Ho In, Taesung Park, Young Kee Shin. The Cancer Gene Expression Bank (CGEB) (11.6-7) 2nd International Conference on Toxicogenomics, 2006 |
|
|
|
|
|
Mi Jeong Kwon, Ensel Oh, Seungmook Lee, Mi Ra Roh, Yong-Ho In, Taesung Park, Sang Seok Koh, Young Kee Shin. Identification of endogenous reference genes using gene expression data produced by EST, SAGE and oligonucleotide microarray. (9.14-16) The 7th international Conference of Korean Society for Bioinformatics (KSBI)., 2006 |
|
|
|
|
|
Ensel Oh, Mira Roh, Seoung Mook Lee, Mi Jeong Kwon, Yong-Ho In, Taesung Park, Young Kee Shin. The Cancer Gene Expression Bank (CGEB) (9.14-16) The 7th international Conference of Korean Society for Bioinformatics (KSBI)., 2006 |
|
|
|
|
|
Joydeb K. Kundu, Young K. Shin, Young Joon Surh. Formulated oligomeric polyphenols (oligonol) from grape seeds inhibit phorbol ester-induced tumor promotion and COX-2 expression in mouse skin: nuclear factor-κB and CCAAT/enhancer binding protein as potential targets (4.1-5) 97th AACR Annual Meeting, 2006 |
|
|
|
|
|
Joydeb Kumar Kundu, Young Kee Shin, Young-Joon Surh. Resveratrol inhibits phorbol ester-induced expression of COX-2 through inactivation of NF-kB and AP-1 in mouse skin: role of IkB kinase and MAP kinases. (1.25-28). Cell Signaling World 2006 Signal Transduction Pathways as therapeutic targets, 2006 |
|
|
|
|
|
Jung Hyun Lee, Seok Hyung Kim, Li-Hui Wang, Choi Yoon-La, Hong Yun Chul, Young Kee Shin. Clinical significance of CD99 downregulation and its mechanism in gastric adenocarcinoma. (11.28-29) (사)대한약학회 2005년도 추계총회 및 학술대회 (poster), 2005 |
|
|
|
|
|
Jung Chul Lee, Joydeb Kumar Kundu, Young Kee Shin, Dal-Mi Hwang, Young-Joon Surh. Humulone inhibits expression of COX-2 in phorbol ester-treated mouse skin by blocking activation of IkB kinase and MAPKs. (11.28-29) (사)대한약학회 2005년도 추계총회 및 학술대회 (poster), 2005 |
|
|
|
|
|
Li-Hui Wang, Jung Hyun Lee, Hun Soon Jung, Seok Hyung Kim, Yun Chul Hong, Young Kee Shin. Characterization of SMAD4 down-regulation in Gastric Carcinoma. (2005) Promising Next Generation Technology of Toxicogenomics in Drug and Food Safety, and Environmental Health (poster), 2005 |
|
|
|
|
|
Joydeb Kumar Kundu, Sue Ok Kim, Young Kee Shin, Jin-hong Park, Myung-Haing Cho, Young-Joon Surh. [6]-Gingerol inhibits phobol ester-induced COX-2 expression in mouse skin by blocking the activation NF-kB and p38 MAP kinase. (9.7-9.9). 18th ASIA Pacific Cancer Conference Toward The Tailored Therapy for Cancer "Cancer Research and Treatment" (poster), 2005 |
|
|
|
|
|
Kundu JK, Shin YK, Kim Y-C, Surh Y-J. Resveratrol inhibits phobol ester-induced expression of COX-2 and activation of NF-kB in mouse skin by blocking IkB kinase -b activity. (9.3-9.9) 9th International Conference Conference on Environmental Mutagens &36th Annual Meeting of The Environmental Mutagen Society. (poster), 2005 |
|
|
|
|
|
Joydeb Kumar Kundu, Dal-Mi Hwang, Jung-Chul Lee, Eun-Jin Chang, Young Kee Shin, Buxiang Sun, Young-Joon Surh. Oligonol inhibits phorbol ester-induced tumor promotion, expression of COX-2 and activation of nuclear factor-kB in mouse skin. (5.20 -21, 2005) ISCaP symposium in kyoto "Molecular Targeting Cancer Chemoprevention" (Invited lecture), 2005 |
|
|
|
|
|
Kundu JK, Hwang D-M, Lee J-C, Chang E-J, Shin YK, Sun B, Surh Y-J. Oligonol inhibits chemically-induced papillogenesis, expression of COX-2 and activation of nuclear factor-kB in mouse skin in vivo. Minisymposium of Veterinary College (Oral presentation), 2005 |
|
|
|
|
|
Sun Hee Lim, Dae Sung Hur, Seung Hwa Jeon, Jeoung Ku Hwang, Seong Hwan Kim, Alexey Dan Chin-Yu, Seung Jin Her, No Woong Kwak, Sang Soon Yoon, Young Kee Shin, Chanil Chung, and Jun Keun Chang. Practical Use of Disposable Plastic Micro-fluidic Chip for Cell Viability Test. 한국미생물생명공학회 (poster), 2004 |
|
|
|
|
|
Seok Hyung Kim, Young Kee Shin. Expression of TGF-beta related signaling molecules and gastric carcinoma. International Symposium on “Critical Roles of Toxicogenomics and Toxicoproteomics in Human Health and Environment” for commemoration of the Korean Society of Toxicogenomics and Toxicoproteomics (poster), 2004 |
|
|
|
|
|
Seok Hyung Kim, Young Kee Shin. Downregulation of CD99 correlates with poor prognosis of gastric carcinoma. International Symposium on “Critical Roles of Toxicogenomics and Toxicoproteomics in Human Health and Environment” for commemoration of the Korean Society of Toxicogenomics and Toxicoproteomics (poster), 2004 |
|
|
|
|
|
|
|
|
Title: Prognostic Genes for Early Breast Cancer and Prognostic Model for Early Breast Cancer Patients (초기유방암의 예후 예측용 유전자 및 이를 이용한 초기유방암의 예후예
측 방법)
Inventor:Young Kee Shin, Yul-la Choi, Young-Deug, Kim, Oh eusol, Kim Siun
Assignee: Rererence Biolabs.
Application Number: 10-2011-0000521 (대한민국 출원), 2011 |
|
|
|
|
|
Title: Multi-transmenbrane's extradomain domain-derived antigen and their Antibody and Uses Thereof (복합 막횡단 단백질의 세포막외 펩타이드 부위를 항원으로 활용한 항체 및 항체 단편의 제조와 그의 용도)
Inventor: Young Kee Shin, Young-Deug, Kim, Jun-Young Choi, Myung-Suk Lee
Assignee: Reference Biolabs.
Application Number: 10-2011-0011475 (대한민국 출원), 2011 |
|
|
|
|
|
Title: COMPOSITION FOR TREATMENT OF Cancer of HPV relative (2010.11.08)
Inventor: Young Kee Shin, Hun Soon Jung
Assignee: E-gen Biotech
Application Number: PCT/KR2011/000365 (PCT), 2010 |
|
|
|
|
|
Title: HPV 감염과 관련된 암의 치료용 조성물 (COMPOSITION FOR TREATMENT OF Cancer of HPV relative) (2010.11.08)
Inventor: Young Kee Shin, Hun Soon Jung
Assignee: E-gen Biotech
Application Number: 10-2010-0004311 (대한민국 출원), 2010 |
|
|
|
|
|
Title: Data processing, analysis method of gene expression data to identify endogenous reference genes (2009.07.16)
Inventor: Young Kee Shin, Mi Jeong Kwon, En Sel Oh, Yong Ho In, Sang Seok Koh
Assignee: SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION
Application Number: 2009-543947 (EP 출원), 2009 |
|
|
|
|
|
Title: Data processing, analysis method of gene expression data to identify endogenous reference genes (2009.06.26)
Inventor: Young Kee Shin, Mi Jeong Kwon, En Sel Oh, Yong Ho In, Sang Seok Koh
Assignee: SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION
Application Number: 2009-543947 (일본 출원공개), 2009 |
|
|
|
|
|
Title: Data processing, analysis method of gene expression data to identify endogenous reference genes (2009.06.26)
Inventor: Young Kee Shin, Mi Jeong Kwon, En Sel Oh, Yong Ho In, Sang Seok Koh
Assignee: SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION
Application Number: 12/521,498 (미국 출원공개), 2009 |
|
|
|
|
|
Title: 웹기반의 원격진단을 구현하는 방법 및 장치 (METHOD AND APPARATUS FOR IMPLEMENTING A WEB-BASED REMOTE DIAGNOSIS) (2008.07.01)
Inventor: Young Kee Shin, Jong-Hun Lee
Assignee: 씨엘아이티 주식회사
Patent Number: 10-0844543 (Republic of Korea), 2008 |
|
|
|
|
|
Title: Data processing, analysis method of gene expression data to identify endogenous reference genes (2007.12.27)
Inventor: Young Kee Shin, Mi Jeong Kwon, En Sel Oh, Yong Ho In, Sang Seok Koh
Assignee: SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION
Application Number: PCT/KR2007/006890, 2007 |
|
|
|
|
|
Title: 인간 인터페론-베타 변이체 및 그 제조방법 (Human interferon-beta mutein) (2007.11.27)
Inventor: Young Kee Shin, Kyung Song, Tae Ho Byun, Jong-Min Lee, Jae Ho Jin
Assignee: Young Kee Shin
Patent Number: 0781666 (Republic of Korea), 2007 |
|
|
|
|
|
Title: COMPOSITION FOR TREATMENT OF CERVIX CANCER (2007.11.05)
Inventor: Young Kee Shin, Hun Soon Jung, Yu-Kyoung Oh
Assignee: SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION
Application Number: PCT/KR2007/005548, 2007 |
|
|
|
|
|
Title: Method to inhibit cancer targeting CD24 (2007.07.02)
Inventor: Young Kee SHin, Yoo-La Choi, Young Woo Park, Seung Hyun Lee
Assignee: SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION
Application Number: PCT/KR2007/005548, 2007 |
|
|
|
|
|
Title: Human interferon-beta mutein (2007.05.23)
Inventor: Young Kee Shin, Kyung Song, Tae Ho Byun, Jong-Min Lee, Jae Ho Jin
Assignee: Young Kee Shin
Application Number: 05804508 (EP), 2007 |
|
|
|
|
|
Title: Human interferon-beta mutein (2007.05.18)
Inventor: Young Kee Shin, Kyung Song, Tae Ho Byun, Jong-Min Lee, Jae Ho Jin
Assignee: Young Kee Shin
Application Number: 3732/DELNP/2007 (India), 2007 |
|
|
|
|
|
Title: Human interferon-beta mutein (2007.05.02)
Inventor: Young Kee Shin, Kyung Song, Tae Ho Byun, Jong-Min Lee, Jae Ho Jin
Assignee: Young Kee Shin
Application Number:20070055840(Brazil), 2007 |
|
|
|
|
|
Title: Human interferon-beta mutein (2007.05.02)
Inventor: Young Kee Shin, Kyung Song, Tae Ho Byun, Jong-Min Lee, Jae Ho Jin
Assignee: Young Kee Shin
Application Number: 2007-540249 (Japan), 2007 |
|
|
|
|
|
Title: Human interferon-beta mutein (2007.05.02)
Inventor: Young Kee Shin, Kyung Song, Tae Ho Byun, Jong-Min Lee, Jae Ho Jin
Assignee : Young Kee Shin
Application Number: 11/718,499 (USA), 2007 |
|
|
|
|
|
Title: Human interferon-beta mutein (2007.05.02)
Inventor: Young Kee Shin, Kyung Song, Tae Ho Byun, Jong-Min Lee, Jae Ho Jin
Assignee: Young Kee Shin
Application Number: 200580045291 (China), 2007 |
|
|
|
|
|
Title: 표준 발현 유전자를 발굴하기 위한 유전자 발현 데이터 처리, 분석 방법 및 상기 방법에 의해 수득한 표준 발현 유전자 (Data processing, analysis method of gene expression data to identify endogenous reference genes) (2006.11.27)
Inventor: Young Kee Shin, Mi Jeong Kwon, En Sel Oh, Yong Ho In, Sang Seok Koh
Assignee: SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION
Application Number: 10-2006-134883, 2006 |
|
|
|
|
|
Title: 자궁경부암을 위한 치료용 조성물 (COMPOSITION FOR TREATMENT OF CERVIX CANCER) (2006.11.03)
Inventor: Young Kee Shin, Hun Soon Jung, Yu-Kyoung Oh
Assignee: SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION
Application Number: 10-2006-0108352, 2006 |
|
|
|
|
|
Title:다이컴을 이용한 의료 영상 진단 시스템, 장치 및 방법 (2006.09.29)
Inventor: Young Kee Shin, Jong-Hun Lee
Assignee: MEDICAL TELEPACS CENTER CO., LTD
Application Number: 10-2006-0096277, 2006 |
|
|
|
|
|
Title: CD24를 표적으로 하는 암억제방법 (Method to inhibit cancer targeting CD24) (2006.06.30)
Inventor: Young Kee Shin, Yoo-La Choi, Young Woo Park, Seung Hyun Lee
Assignee: SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION
Application Number: 10-2006-0061119, 2006 |
|
|
|
|
|
Title: PDE4B2의 단일클론 항체를 진단표지자로 이용한 뇌종양의 진단방법 (A method of diagnosing brain tumor using by monoclonal antibody against PDE4B2 as a diagnostic marker)(2004.06.18)
Inventor: 문은이, 신영기, 유대열, 김환묵, 박성규
Assignee: 한국생명공학연구원
Application Number: 2004-0045452, 2004 |
|
|
|
|
|
|
|
|
강영진, 강주섭, 김미려, 김미정, 김상현, 김선영, 김순애, 김용식, 김윤균, 김헌식, 김혜정, 박지영, 석경호, 석정호, 성기욱, 소윤조, 손의동, 신영기, 유은숙, 윤영란, 이경은, 이기호, 이대희, 이석용, 이성룡, 이원석, 장기철, 정원석, 제현동,조민경, 차인준, 최철희, 최형철, 하정희, 한성규. (35인) 하버드핵심약리학: 약물요법의 병태생리학적 기초, 국내 범문사, 총 870면 [역서], 2005-09 발행, 2005 |
|
|
|
|
|
|
|
